# The Nottingham recovery from COVID-19 research platform (NoRCoRP): Functional, clinical and patient-reported outcomes in adults referred to a post-COVID respiratory service

**Authors:** Malik Hamrouni, Ayushman Gupta, Sophie Middleton, Sabrina Prosper, Theresa Harvey-Dunstan, Joanne Porte, Tricia M. McKeever, Ian P. Hall, Charlotte E. Bolton

PMC · DOI: 10.1371/journal.pone.0344210 · 2026-03-05

## TL;DR

This study examines the long-term effects of COVID-19 on non-hospitalized adults, finding that breathing issues, physical deconditioning, and mental health problems are major factors affecting recovery.

## Contribution

The study identifies key factors associated with persistent respiratory symptoms post-COVID in non-hospitalized adults using a multidimensional assessment approach.

## Key findings

- Dysregulated breathing, deconditioning, and psychological distress were major contributors to symptom burden in post-COVID patients.
- Higher BMI and depression were linked to clinically significant breathlessness.
- Female sex, smoking, and mental health issues were associated with dysregulated breathing.

## Abstract

To characterise symptoms, function and patient-reported outcome measures (PROMs), and identify associated factors in adults with persisting respiratory symptoms post-COVID.

Cross-sectional analysis of 210 non-hospitalised adults referred to a post-COVID respiratory clinic (December 2020-July 2024) who consented to research. Assessments included demographics, symptoms, lung function, chest CT, and several PROMs: MRC dyspnoea score, Nijmegen Questionnaire score (NQ), Hospital Anxiety and Depression Scale, Chalder Fatigue Scale, Short Physical Performance Battery (SPPB) and Fried Frailty Index. Multivariate logistic regression examined key exposure-outcome associations.

Among participants (mean age 49.4 years; 68% female; median 13.3 months since COVID-19 diagnosis), 95% reported shortness of breath, 54% had clinically significant breathlessness (MRC ≥ 3), 68% had an NQ score (>23) consistent with dysregulated breathing, 32% had a low SPPB score (<10), and 77% were classed as frail/pre-frail, despite the majority being of working age. Nearly half (47%) of those employed pre-infection had not returned to previous hours. Spirometry and CT abnormalities were not common. Higher body mass index (odds ratio = 1.10, 95% confidence interval = 1.05–1.16, n in model = 190) and depression (2.25, 1.13–4.56, n = 164) were associated with MRC ≥ 3. Dysregulated breathing was associated with female sex (3.63, 1.77–7.60, n = 186), current/ex-smoker (2.56, 1.25–5.47, n = 186), fatigue (8.87, 2.59–37.0, n = 162), anxiety (3.57, 1.70–7.69, n = 162) and depression (5.70, 2.59–13.40, n = 162). A low SPPB score was associated with female sex, current smoking, depression, clinically significant breathlessness, dysregulated breathing, and greater deprivation.

In non-hospitalised patients with persistent respiratory symptoms post-COVID, dysregulated breathing, deconditioning and psychological distress were key factors linked with symptom burden. These findings suggest a multidisciplinary approach should be considered to optimise recovery.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}
- **Diseases:** fibrosis (MESH:D005355), post-COVID respiratory symptoms (MESH:D012818), CT abnormalities (MESH:D000014), persistent (MESH:D000088562), atelectasis (MESH:D001261), bronchiectasis (MESH:D001987), parenchymal abnormality (MESH:D002543), impaired sleep quality (MESH:D012893), respiratory disease (MESH:D012140), weakness (MESH:D018908), lung abnormalities (MESH:D008171), COVID symptoms (MESH:D000086382), reduced physical capacity (MESH:D001523), interstitial abnormalities (MESH:D065167), breathlessness (MESH:D004417), infection (MESH:D007239), asthma (MESH:D001249), emphysema (MESH:D004646), Anxiety (MESH:D001007), cough (MESH:D003371), weight loss (MESH:D015431), adiposity (MESH:D018205), Depression (MESH:D003866), smoking (MESH:D015208), respiratory (MESH:D012131), weight gain (MESH:D015430), low mood (MESH:D019964), CT abnormalities (MESH:C000719218), muscle aches (MESH:D063806), Airflow obstruction (MESH:D029424), Fatigue (MESH:D005221), lung parenchymal abnormalities (MESH:D017563), functional limitation (MESH:D045745), dysfunctional breathing (MESH:D012891), Dysregulated breathing (MESH:D021081), long COVID (MESH:D000094024), Frailty (MESH:D000073496), Functional impairment (MESH:D003072), brain fog (MESH:D005222)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962452/full.md

---
Source: https://tomesphere.com/paper/PMC12962452